Infection prevention control and organisational patient safety culture within the context of isolation: study protocol.

Cultural change Healthcare associated infection Implementation theory Infection prevention control Isolation MaPSaF Manchester patient safety framework Patient safety culture Qualitative research

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
08 May 2019
Historique:
received: 03 10 2018
accepted: 25 04 2019
entrez: 10 5 2019
pubmed: 10 5 2019
medline: 26 7 2019
Statut: epublish

Résumé

Healthcare associated infection (HCAI) is a major cause of morbidity and mortality. In recent years, there have been high profile successes in infection prevention control (IPC), such as the dramatic reductions in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (which is viewed as one proxy indicator of overall harm) and Clostridium difficile in the UK. Nevertheless, HCAI remains a costly burden to health services, a source of concern to patients and the public and at present, is receiving priority from policy makers as it contributes to the global threat of antimicrobial resistance. The study involves qualitative case studies within isolation settings at two National Health Service (NHS) district general hospitals (DGHs) in Wales, in the UK. The 18-month study incorporates Manchester Patient Safety Framework (MaPSaF) workshops with health workers and other hospital staff, in depth interviews with patients and their relative / informal carer, health workers and hospital staff, and periods of hospital ward observation. The present study aims to investigate the ways in which engagement of health workers with IPC strategies and principles, shape and inform organisational patient safety culture within the context of isolation in surgical, medical and admission hospital settings; and vice-versa. We want to understand the meaning of IPC 'ownership' for health workers; the ways in which IPC is promoted, how IPC teams operate as new challenges arise, how their effectiveness is assessed and the positioning of IPC within the broader context of organisational patient safety culture, within hospital isolation settings.

Sections du résumé

BACKGROUND BACKGROUND
Healthcare associated infection (HCAI) is a major cause of morbidity and mortality. In recent years, there have been high profile successes in infection prevention control (IPC), such as the dramatic reductions in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (which is viewed as one proxy indicator of overall harm) and Clostridium difficile in the UK. Nevertheless, HCAI remains a costly burden to health services, a source of concern to patients and the public and at present, is receiving priority from policy makers as it contributes to the global threat of antimicrobial resistance.
METHODS METHODS
The study involves qualitative case studies within isolation settings at two National Health Service (NHS) district general hospitals (DGHs) in Wales, in the UK. The 18-month study incorporates Manchester Patient Safety Framework (MaPSaF) workshops with health workers and other hospital staff, in depth interviews with patients and their relative / informal carer, health workers and hospital staff, and periods of hospital ward observation.
DISCUSSION CONCLUSIONS
The present study aims to investigate the ways in which engagement of health workers with IPC strategies and principles, shape and inform organisational patient safety culture within the context of isolation in surgical, medical and admission hospital settings; and vice-versa. We want to understand the meaning of IPC 'ownership' for health workers; the ways in which IPC is promoted, how IPC teams operate as new challenges arise, how their effectiveness is assessed and the positioning of IPC within the broader context of organisational patient safety culture, within hospital isolation settings.

Identifiants

pubmed: 31068203
doi: 10.1186/s12913-019-4126-x
pii: 10.1186/s12913-019-4126-x
pmc: PMC6507018
doi:

Types de publication

Journal Article

Langues

eng

Pagination

296

Références

J Hosp Infect. 2003 Jul;54(3):171-3
pubmed: 12855230
J Hosp Infect. 2003 Aug;54(4):258-66; quiz 321
pubmed: 12919755
J Hosp Infect. 2006 May;63 Suppl 1:S1-44
pubmed: 16581155
Soc Sci Med. 2013 Feb;78:26-33
pubmed: 23246396
Br J Nurs. 2018 Feb 8;27(3):137-140
pubmed: 29412028
Am J Infect Control. 1996 Jun;24(3):203-6
pubmed: 8806999
BMJ Qual Saf. 2013 Nov;22(11):885-7
pubmed: 24046440
Nurs Stand. 2000 Apr 5-11;14(29):32-6
pubmed: 11309925
J Res Nurs. 2019 Dec;24(8):677-693
pubmed: 34394593
Nurs Times. 1993 Jul 28-Aug 3;89(30):53-6
pubmed: 8233859
Healthc Pap. 2013;13(1):6-22
pubmed: 23803349
Qual Health Res. 2003 Jul;13(6):871-83
pubmed: 12891720
Am J Infect Control. 2006 Oct;34(8):507-12
pubmed: 17015156
Nurs Stand. 2000 Mar 29-Apr 4;14(28):35-8
pubmed: 11310068
N Engl J Med. 2003 Feb 13;348(7):651-6
pubmed: 12584377
Ann Intern Med. 2002 Oct 15;137(8):665-70
pubmed: 12379067
BMJ. 2000 Mar 18;320(7237):777-81
pubmed: 10720366
Am J Infect Control. 2007 Dec;35(10 Suppl 2):S65-164
pubmed: 18068815
J Hosp Infect. 2014 Jan;86(1):1-6
pubmed: 24309419
Jt Comm J Qual Patient Saf. 2009 May;35(5):239-46
pubmed: 19480375
Infect Control Hosp Epidemiol. 2014 Sep;35 Suppl 2:S32-47
pubmed: 25376068
Health Technol Assess. 2003;7(39):1-194
pubmed: 14636487
J Hosp Infect. 2016 Sep;94(1):41-7
pubmed: 26996088
Am J Infect Control. 2006 Oct;34(8):484-94
pubmed: 17015153
Infect Control Hosp Epidemiol. 2003 May;24(5):362-86
pubmed: 12785411
Br J Nurs. 2018 Jan 25;27(2):88-91
pubmed: 29368561
Am J Infect Control. 2013 Nov;41(11):959-64
pubmed: 23880116
Int J Qual Health Care. 2003 Apr;15(2):111-8
pubmed: 12705704
BMC Health Serv Res. 2006 Jul 07;6:86
pubmed: 16827928
BMJ. 2000 Mar 18;320(7237):725-6
pubmed: 10720335
J Hosp Infect. 2006 Jan;62(1):6-21
pubmed: 16310890
J Hosp Infect. 2016 Dec;94(4):373-380
pubmed: 27810221
Med Care. 2014 Feb;52(2 Suppl 1):S4-8
pubmed: 24430265
J Hosp Infect. 2015 Feb;89(2):77-81
pubmed: 25549828
Implement Sci. 2013 Feb 13;8:18
pubmed: 23406398
J Health Serv Res Policy. 2003 Apr;8(2):105-17
pubmed: 12820673

Auteurs

John Gammon (J)

College of Human and Health Sciences, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK.

Julian Hunt (J)

College of Human and Health Sciences, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK. J.Hunt@Swansea.ac.uk.

Sharon Williams (S)

College of Human and Health Sciences, Swansea University, Singleton Park, Swansea, SA2 8PP, Wales, UK.

Sharon Daniel (S)

Infection Prevention and Control, Hywel Dda University Health Board, Carmarthen, Wales, UK.

Sue Rees (S)

Infection Prevention and Control, Hywel Dda University Health Board, Carmarthen, Wales, UK.

Sian Matthewson (S)

Infection Prevention and Control, Hywel Dda University Health Board, Carmarthen, Wales, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH